Jamal S Rana1, Grace H Tabada2, Matthew D Solomon3, Joan C Lo4, Marc G Jaffe5, Sue Hee Sung2, Christie M Ballantyne6, Alan S Go7. 1. Division of Cardiology, Kaiser Permanente Northern California, Oakland, California; Division of Research, Kaiser Permanente Northern California, Oakland, California; Department of Medicine, University of California, San Francisco, San Francisco, California. 2. Division of Research, Kaiser Permanente Northern California, Oakland, California. 3. Division of Cardiology, Kaiser Permanente Northern California, Oakland, California; Division of Research, Kaiser Permanente Northern California, Oakland, California; Department of Medicine, Stanford University, Stanford, California. 4. Division of Research, Kaiser Permanente Northern California, Oakland, California; Department of Medicine, University of California, San Francisco, San Francisco, California; Division of Endocrinology, Kaiser Permanente Oakland Medical Center, Oakland, California. 5. Department of Medicine, University of California, San Francisco, San Francisco, California; Division of Endocrinology, Kaiser Permanente South San Francisco Medical Center, South San Francisco, California. 6. Section of Cardiovascular Research, Department of Medicine, Baylor College of Medicine, and Center for Cardiovascular Disease Prevention, Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas. 7. Division of Research, Kaiser Permanente Northern California, Oakland, California; Department of Medicine, University of California, San Francisco, San Francisco, California; Departments of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California; Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California. Electronic address: alan.s.go@kp.org.
Abstract
BACKGROUND: The accuracy of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Pooled Cohort Risk Equation for atherosclerotic cardiovascular disease (ASCVD) events in contemporary and ethnically diverse populations is not well understood. OBJECTIVES: The goal of this study was to evaluate the accuracy of the 2013 ACC/AHA Pooled Cohort Risk Equation within a large, multiethnic population in clinical care. METHODS: The target population for consideration of cholesterol-lowering therapy in a large, integrated health care delivery system population was identified in 2008 and followed up through 2013. The main analyses excluded those with known ASCVD, diabetes mellitus, low-density lipoprotein cholesterol levels <70 or ≥190 mg/dl, prior lipid-lowering therapy use, or incomplete 5-year follow-up. Patient characteristics were obtained from electronic medical records, and ASCVD events were ascertained by using validated algorithms for hospitalization databases and death certificates. We compared predicted versus observed 5-year ASCVD risk, overall and according to sex and race/ethnicity. We additionally examined predicted versus observed risk in patients with diabetes mellitus. RESULTS: Among 307,591 eligible adults without diabetes between 40 and 75 years of age, 22,283 were black, 52,917 were Asian/Pacific Islander, and 18,745 were Hispanic. We observed 2,061 ASCVD events during 1,515,142 person-years. In each 5-year predicted ASCVD risk category, observed 5-year ASCVD risk was substantially lower: 0.20% for predicted risk <2.50%; 0.65% for predicted risk 2.50% to <3.75%; 0.90% for predicted risk 3.75% to <5.00%; and 1.85% for predicted risk ≥5.00% (C statistic: 0.74). Similar ASCVD risk overestimation and poor calibration with moderate discrimination (C statistic: 0.68 to 0.74) were observed in sex, racial/ethnic, and socioeconomic status subgroups, and in sensitivity analyses among patients receiving statins for primary prevention. Calibration among 4,242 eligible adults with diabetes was improved, but discrimination was worse (C statistic: 0.64). CONCLUSIONS: In a large, contemporary "real-world" population, the ACC/AHA Pooled Cohort Risk Equation substantially overestimated actual 5-year risk in adults without diabetes, overall and across sociodemographic subgroups.
BACKGROUND: The accuracy of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Pooled Cohort Risk Equation for atherosclerotic cardiovascular disease (ASCVD) events in contemporary and ethnically diverse populations is not well understood. OBJECTIVES: The goal of this study was to evaluate the accuracy of the 2013 ACC/AHA Pooled Cohort Risk Equation within a large, multiethnic population in clinical care. METHODS: The target population for consideration of cholesterol-lowering therapy in a large, integrated health care delivery system population was identified in 2008 and followed up through 2013. The main analyses excluded those with known ASCVD, diabetes mellitus, low-density lipoprotein cholesterol levels <70 or ≥190 mg/dl, prior lipid-lowering therapy use, or incomplete 5-year follow-up. Patient characteristics were obtained from electronic medical records, and ASCVD events were ascertained by using validated algorithms for hospitalization databases and death certificates. We compared predicted versus observed 5-year ASCVD risk, overall and according to sex and race/ethnicity. We additionally examined predicted versus observed risk in patients with diabetes mellitus. RESULTS: Among 307,591 eligible adults without diabetes between 40 and 75 years of age, 22,283 were black, 52,917 were Asian/Pacific Islander, and 18,745 were Hispanic. We observed 2,061 ASCVD events during 1,515,142 person-years. In each 5-year predicted ASCVD risk category, observed 5-year ASCVD risk was substantially lower: 0.20% for predicted risk <2.50%; 0.65% for predicted risk 2.50% to <3.75%; 0.90% for predicted risk 3.75% to <5.00%; and 1.85% for predicted risk ≥5.00% (C statistic: 0.74). Similar ASCVD risk overestimation and poor calibration with moderate discrimination (C statistic: 0.68 to 0.74) were observed in sex, racial/ethnic, and socioeconomic status subgroups, and in sensitivity analyses among patients receiving statins for primary prevention. Calibration among 4,242 eligible adults with diabetes was improved, but discrimination was worse (C statistic: 0.64). CONCLUSIONS: In a large, contemporary "real-world" population, the ACC/AHA Pooled Cohort Risk Equation substantially overestimated actual 5-year risk in adults without diabetes, overall and across sociodemographic subgroups.
Authors: Maryam Kavousi; Maarten J G Leening; David Nanchen; Philip Greenland; Ian M Graham; Ewout W Steyerberg; M Arfan Ikram; Bruno H Stricker; Albert Hofman; Oscar H Franco Journal: JAMA Date: 2014-04-09 Impact factor: 56.272
Authors: Paul Muntner; Lisandro D Colantonio; Mary Cushman; David C Goff; George Howard; Virginia J Howard; Brett Kissela; Emily B Levitan; Donald M Lloyd-Jones; Monika M Safford Journal: JAMA Date: 2014-04-09 Impact factor: 56.272
Authors: Andrew P DeFilippis; Rebekah Young; Christopher J Carrubba; John W McEvoy; Matthew J Budoff; Roger S Blumenthal; Richard A Kronmal; Robyn L McClelland; Khurram Nasir; Michael J Blaha Journal: Ann Intern Med Date: 2015-02-17 Impact factor: 25.391
Authors: Robert W Yeh; Stephen Sidney; Malini Chandra; Michael Sorel; Joseph V Selby; Alan S Go Journal: N Engl J Med Date: 2010-06-10 Impact factor: 91.245
Authors: Nivee P Amin; Seth S Martin; Michael J Blaha; Khurram Nasir; Roger S Blumenthal; Erin D Michos Journal: J Am Coll Cardiol Date: 2014-05-07 Impact factor: 24.094
Authors: Mark A Hlatky; Roberta M Ray; Dale R Burwen; Karen L Margolis; Karen C Johnson; Anna Kucharska-Newton; JoAnn E Manson; Jennifer G Robinson; Monika M Safford; Matthew Allison; Themistocles L Assimes; Anthony A Bavry; Jeffrey Berger; Rhonda M Cooper-DeHoff; Susan R Heckbert; Wenjun Li; Simin Liu; Lisa W Martin; Marco V Perez; Hilary A Tindle; Wolfgang C Winkelmayer; Marcia L Stefanick Journal: Circ Cardiovasc Qual Outcomes Date: 2014-01-07
Authors: Charlotte Andersson; Danielle Enserro; Martin G Larson; Vanessa Xanthakis; Ramachandran S Vasan Journal: J Am Heart Assoc Date: 2015-04-17 Impact factor: 5.501
Authors: Andrew J Karter; Dean Schillinger; Alyce S Adams; Howard H Moffet; Jennifer Liu; Nancy E Adler; Alka M Kanaya Journal: Diabetes Care Date: 2012-10-15 Impact factor: 19.112
Authors: Meredith S Duncan; Matthew S Freiberg; Robert A Greevy; Suman Kundu; Ramachandran S Vasan; Hilary A Tindle Journal: JAMA Date: 2019-08-20 Impact factor: 56.272
Authors: Gregory E Simon; Eric Johnson; Jean M Lawrence; Rebecca C Rossom; Brian Ahmedani; Frances L Lynch; Arne Beck; Beth Waitzfelder; Rebecca Ziebell; Robert B Penfold; Susan M Shortreed Journal: Am J Psychiatry Date: 2018-05-24 Impact factor: 18.112
Authors: Michael T Lu; Nandini M Meyersohn; Thomas Mayrhofer; Daniel O Bittner; Hamed Emami; Stefan B Puchner; Borek Foldyna; Martin E Mueller; Steven Hearne; Clifford Yang; Stephan Achenbach; Quynh A Truong; Brian B Ghoshhajra; Manesh R Patel; Maros Ferencik; Pamela S Douglas; Udo Hoffmann Journal: Radiology Date: 2017-11-27 Impact factor: 11.105
Authors: Samia Mora; Nanette K Wenger; Nancy R Cook; Jingmin Liu; Barbara V Howard; Marian C Limacher; Simin Liu; Karen L Margolis; Lisa W Martin; Nina P Paynter; Paul M Ridker; Jennifer G Robinson; Jacques E Rossouw; Monika M Safford; JoAnn E Manson Journal: JAMA Intern Med Date: 2018-09-01 Impact factor: 21.873
Authors: Gregory A Phelps; Yanru Qiao; Merrion G Buckley; Junling Wang; Minghui Sam Li; Soumitra S Bhuyan; Marie A Chisholm-Burns Journal: Res Social Adm Pharm Date: 2019-07-25